PDS Biotechnology is a biopharmaceutical company focused on the development and commercialization of therapies based on the versamune platform. Its platform is designed to help the body better recognize, attack and destroy cancer. PDS Biotechnology's pipeline combines the versamune technology with custom-designed tumor-specific antigens, each tailored to specific cancer types.